Table 2.
Characteristics of HCC among cases
| Cases N (%) | |
|---|---|
| Method of HCC diagnosis* | |
| Imaging (CT/MRI) | 160(94.7) |
| Histology | 79(46.7) |
| Treatment of HCC* | |
| Liver transplantation | 2(1.2) |
| Surgery (partial hepatectomy) | 9(5.3) |
| Systemic chemotherapy (sorafenib) | 72(42.6) |
| Trans-arterial chemoembolization | 58(34.3) |
| Radiofrequency ablation | 19(11.2) |
| Y-90 radioembolization | 7(4.1) |
| Percutaneous ethanol injection | 1(0.6) |
| Cryoablation | 0(0.0) |
| Other Treatment | 22(13.0) |
| Any one of the above treatments | 118(69.8) |
| Stage of HCC at Diagnosis | |
| Maximum dimension of largest tumor (cm), mean (SD) | 6.4(4.4) |
| Number of tumors, mean (SD) | 2.2(1.7) |
| Number of tumors (%) | |
| 1 | 86(57.0) |
| 2–3 | 28(18.5) |
| ≥4 | 37(24.5) |
| Size of largest tumor (%) | |
| 0–3 cm | 32(18.9) |
| 3 to <5 cm | 41(24.3) |
| 5 to <6 cm | 8(4.7) |
| 6 to <7 cm | 10(5.9) |
| ≥7 cm | 78(46.2) |
| Within Milan Criteria (%)† | 70(34.4) |
| Beyond Milan Criteria (%) | 117(65.6) |
| Vascular Invasion, % | 47(27.8) |
| Metastasis, % | 24(14.2) |
| HCC Contributed to patient’s death* | |
| Metastatic HCC | 58(34.3) |
| Multifocal HCC (>3 lesions) | 70(41.4) |
| Local or vascular invasion by HCC | 70(41.4) |
| Large Volume HCC (>6cm or AFP>1000) | 124(73.4) |
| Death due to complications of HCC treatment | 5(3.0) |
*
The categories for “method of HCC diagnosis”, “treatment of HCC” and “HCC contributed to patienťs death” are NOT mutually exclusive.
†
Milan Criteria: One tumor <5 cm or 2–3 tumors each of which is < 3cm
Abbreviations: HCC – hepatocellular carcinoma, CT – computed tomography, MRI – magnetic resonance imaging, SD – standard deviation, AFP – alpha fetoprotein